Lexaria Bioscience Corp. - *W EXP 01/14/202 (LEXXW)

CUSIP: 52886N117

Q4 2022 13F Holders as of 31 Dec 2022

Share change
-55,051
SEC-reported price per share
$0.40
Indexed holders
4
Value change
-$22,015
Number of buys
1
Number of sells
1

Security key

52886N117

Report period

Q4 2022

Indexed institutions

4

Top holders

4

Ownership snapshot

Top reported holders of LEXXW - Lexaria Bioscience Corp. - *W EXP 01/14/202 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Invenomic Capital Managem...
Disclosed value leader
Invenomic Capital Managem...
Comparable rows
0/15
Latest evidence
30 Sep 2022
13F Highest disclosed value: $1,159,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Invenomic Capital Management LP has the largest disclosed position value at $1.16M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Invenomic Capital Management LP's linked filing trail.
Disclosed position value Top 5
Invenomic Capital Management LP $1.16M
SABBY MANAGEMENT, LLC $699K
BOOTHBAY FUND MANAGEMENT, LLC $193K
GEODE CAPITAL MANAGEMENT, LLC $120K
SUSQUEHANNA INTERNATIONAL GROUP, LLP $98K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Invenomic Capital Management LP
13F
Company
13F
—
denominator unverified
$1,159,000
473,103 shares
— 30 Sep 2022
SABBY MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$699,000
285,360 shares
— 30 Sep 2022
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$193,000
78,950 shares
— 30 Sep 2022
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$120,000
49,002 shares
— 30 Sep 2022
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
13F
—
denominator unverified
$98,000
40,119 shares
— 30 Sep 2022
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$81,000
33,164 shares
— 30 Sep 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
4
Shares
351,259
Indexed holders
4
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 indexed holders
4
Q4 2022 indexed holders
4
Indexed holder difference
0
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 value Q4 2022 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .